TLCD3B and melanoma: In particular, the synthetic anti-cancer drug fenretinide increases the activity of both SPT and ceramide synthase, leading to growth inhibition of neuroblastoma, melanoma, and other tumors (reviewed by Ribatti et al. 2003).